• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Uschner, Diane
    Bott, Matthew
    Lagarde, William H
    Keating, Joseph
    Tapp, Hazel
    Berry, Andrea A
    Seals, Austin L
    Munawar, Iqra
    Schieffelin, John
    Yukich, Joshua
    Santacatterina, Michele
    Gunaratne, Mihili
    Fette, Lida M
    Burke, Brian
    Strylewicz, Greg
    Edelstein, Sharon L
    Ahmed, Amina
    Miller, Kristen
    Sanders, John W
    Herrington, David
    Weintraub, William S
    Runyon, Michael S
    On Behalf Of The Covid-Community Research Partnership
    Show allShow less

    Date
    2022-11-13
    Journal
    Vaccines
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.3390/vaccines10111922
    Abstract
    We characterize the overall incidence and risk factors for breakthrough infection among fully vaccinated participants in the North Carolina COVID-19 Community Research Partnership cohort. Among 15,808 eligible participants, 638 reported a positive SARS-CoV-2 test after vaccination. Factors associated with a lower risk of breakthrough in the time-to-event analysis included older age, prior SARS-CovV-2 infection, higher rates of face mask use, and receipt of a booster vaccination. Higher rates of breakthrough were reported by participants vaccinated with BNT162b2 or Ad26.COV2.S compared to mRNA-1273, in suburban or rural counties compared to urban counties, and during circulation of the Delta and Omicron variants.
    Keyword
    Ad26.COV2.S
    BNT162b2
    Delta
    Omicron
    SARS-CoV-2 vaccination
    age
    booster vaccination
    cumulative incidence
    mRNA-1273
    rural county
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/20234
    ae974a485f413a2113503eed53cd6c53
    10.3390/vaccines10111922
    Scopus Count
    Collections
    UMB Coronavirus Publications
    UMB Open Access Articles

    entitlement

    Related articles

    • Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK).
    • Authors: Vivaldi G, Jolliffe DA, Holt H, Tydeman F, Talaei M, Davies GA, Lyons RA, Griffiths CJ, Kee F, Sheikh A, Shaheen SO, Martineau AR
    • Issue date: 2022 Nov
    • Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    • Authors: Accorsi EK, Britton A, Fleming-Dutra KE, Smith ZR, Shang N, Derado G, Miller J, Schrag SJ, Verani JR
    • Issue date: 2022 Feb 15
    • SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    • Authors: Danza P, Koo TH, Haddix M, Fisher R, Traub E, OYong K, Balter S
    • Issue date: 2022 Feb 4
    • Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    • Authors: Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Coyle P, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Butt AA, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R
    • Issue date: 2021 Nov 16
    • Trends in COVID-19 Vaccine Administration and Effectiveness Through October 2021.
    • Authors: Winkelman TNA, Rai NK, Bodurtha PJ, Chamberlain AM, DeSilva M, Jeruzal J, Johnson SG, Kharbanda A, Klyn N, Mink PJ, Muscoplat M, Waring S, Yu Y, Drawz PE
    • Issue date: 2022 Mar 1
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.